世界のゲノム編集及びゲノム工学市場予測2023-2029:CRISPR、TALEN、ZFN

【英語タイトル】Genome Editing and Genome Engineering Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが出版した調査資料(MMG23FB2185)・商品コード:MMG23FB2185
・発行会社(調査会社):Market Monitor Global
・発行日:2023年2月
・ページ数:65
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後2-3営業日)
・調査対象地域:グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,250 ⇒換算¥494,000見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD4,225 ⇒換算¥642,200見積依頼/購入/質問フォーム
Enterprise User(閲覧人数制限なし)USD4,875 ⇒換算¥741,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界のゲノム編集及びゲノム工学市場規模と予測を収録しています。・世界のゲノム編集及びゲノム工学市場:売上、2018年-2023年、2024年-2029年
・世界のゲノム編集及びゲノム工学市場:販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のゲノム編集及びゲノム工学市場は2022年に000Mドルと評価され、予測期間中に000%のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「CRISPR」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

ゲノム編集及びゲノム工学のグローバル主要企業は、Thermo Fisher Scientific、Merck、Horizon Discovery、Genscript、Sangamo Biosciences、Integrated DNA Technologies、Lonza、New England Biolabs、Origene Technologies、Transposagen Biopharmaceuticals、Editas Medicine、Crispr Therapeutics、Tecan Life Sciencesなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL(MMG)は、ゲノム編集及びゲノム工学のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のゲノム編集及びゲノム工学市場:タイプ別、2018年-2023年、2024年-2029年
世界のゲノム編集及びゲノム工学市場:タイプ別市場シェア、2022年
・CRISPR、TALEN、ZFN

世界のゲノム編集及びゲノム工学市場:用途別、2018年-2023年、2024年-2029年
世界のゲノム編集及びゲノム工学市場:用途別市場シェア、2022年
・細胞株工学、動物遺伝子工学、植物遺伝子工学、その他

世界のゲノム編集及びゲノム工学市場:地域・国別、2018年-2023年、2024年-2029年
世界のゲノム編集及びゲノム工学市場:地域別市場シェア、2022年
・北米:アメリカ、カナダ、メキシコ
・ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
・アジア:中国、日本、韓国、東南アジア、インド
・南米:ブラジル、アルゼンチン
・中東・アフリカ:トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるゲノム編集及びゲノム工学のグローバル売上、2018年-2023年
・主要企業におけるゲノム編集及びゲノム工学のグローバル売上シェア、2022年
・主要企業におけるゲノム編集及びゲノム工学のグローバル販売量、2018年-2023年
・主要企業におけるゲノム編集及びゲノム工学のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Thermo Fisher Scientific、Merck、Horizon Discovery、Genscript、Sangamo Biosciences、Integrated DNA Technologies、Lonza、New England Biolabs、Origene Technologies、Transposagen Biopharmaceuticals、Editas Medicine、Crispr Therapeutics、Tecan Life Sciences

*************************************************************

・調査・分析レポートの概要
ゲノム編集及びゲノム工学市場の定義
市場セグメント
世界のゲノム編集及びゲノム工学市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のゲノム編集及びゲノム工学市場規模
世界のゲノム編集及びゲノム工学市場規模:2022年 VS 2029年
世界のゲノム編集及びゲノム工学市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのゲノム編集及びゲノム工学の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のゲノム編集及びゲノム工学製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分:CRISPR、TALEN、ZFN
ゲノム編集及びゲノム工学のタイプ別グローバル売上・予測

・用途別市場分析
用途区分:細胞株工学、動物遺伝子工学、植物遺伝子工学、その他
ゲノム編集及びゲノム工学の用途別グローバル売上・予測

・地域別市場分析
地域別ゲノム編集及びゲノム工学市場規模 2022年と2029年
地域別ゲノム編集及びゲノム工学売上・予測
北米市場:アメリカ、カナダ、メキシコ
ヨーロッパ市場:ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場:中国、日本、韓国、東南アジア、インド
南米市場:ブラジル、アルゼンチン
中東・アフリカ市場:トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル(企業概要、事業概要、主要製品、売上、ニュースなど)
Thermo Fisher Scientific、Merck、Horizon Discovery、Genscript、Sangamo Biosciences、Integrated DNA Technologies、Lonza、New England Biolabs、Origene Technologies、Transposagen Biopharmaceuticals、Editas Medicine、Crispr Therapeutics、Tecan Life Sciences

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Genome Editing and Genome Engineering Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Genome Editing and Genome Engineering Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Genome Editing and Genome Engineering Overall Market Size
2.1 Global Genome Editing and Genome Engineering Market Size: 2022 VS 2029
2.2 Global Genome Editing and Genome Engineering Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Genome Editing and Genome Engineering Players in Global Market
3.2 Top Global Genome Editing and Genome Engineering Companies Ranked by Revenue
3.3 Global Genome Editing and Genome Engineering Revenue by Companies
3.4 Top 3 and Top 5 Genome Editing and Genome Engineering Companies in Global Market, by Revenue in 2022
3.5 Global Companies Genome Editing and Genome Engineering Product Type
3.6 Tier 1, Tier 2 and Tier 3 Genome Editing and Genome Engineering Players in Global Market
3.6.1 List of Global Tier 1 Genome Editing and Genome Engineering Companies
3.6.2 List of Global Tier 2 and Tier 3 Genome Editing and Genome Engineering Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Genome Editing and Genome Engineering Market Size Markets, 2022 & 2029
4.1.2 CRISPR
4.1.3 TALEN
4.1.4 ZFN
4.2 By Type – Global Genome Editing and Genome Engineering Revenue & Forecasts
4.2.1 By Type – Global Genome Editing and Genome Engineering Revenue, 2018-2023
4.2.2 By Type – Global Genome Editing and Genome Engineering Revenue, 2024-2029
4.2.3 By Type – Global Genome Editing and Genome Engineering Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Genome Editing and Genome Engineering Market Size, 2022 & 2029
5.1.2 Cell Line Engineering
5.1.3 Animal Genetic Engineering
5.1.4 Plant Genetic Engineering
5.1.5 Others
5.2 By Application – Global Genome Editing and Genome Engineering Revenue & Forecasts
5.2.1 By Application – Global Genome Editing and Genome Engineering Revenue, 2018-2023
5.2.2 By Application – Global Genome Editing and Genome Engineering Revenue, 2024-2029
5.2.3 By Application – Global Genome Editing and Genome Engineering Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Genome Editing and Genome Engineering Market Size, 2022 & 2029
6.2 By Region – Global Genome Editing and Genome Engineering Revenue & Forecasts
6.2.1 By Region – Global Genome Editing and Genome Engineering Revenue, 2018-2023
6.2.2 By Region – Global Genome Editing and Genome Engineering Revenue, 2024-2029
6.2.3 By Region – Global Genome Editing and Genome Engineering Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Genome Editing and Genome Engineering Revenue, 2018-2029
6.3.2 US Genome Editing and Genome Engineering Market Size, 2018-2029
6.3.3 Canada Genome Editing and Genome Engineering Market Size, 2018-2029
6.3.4 Mexico Genome Editing and Genome Engineering Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Genome Editing and Genome Engineering Revenue, 2018-2029
6.4.2 Germany Genome Editing and Genome Engineering Market Size, 2018-2029
6.4.3 France Genome Editing and Genome Engineering Market Size, 2018-2029
6.4.4 U.K. Genome Editing and Genome Engineering Market Size, 2018-2029
6.4.5 Italy Genome Editing and Genome Engineering Market Size, 2018-2029
6.4.6 Russia Genome Editing and Genome Engineering Market Size, 2018-2029
6.4.7 Nordic Countries Genome Editing and Genome Engineering Market Size, 2018-2029
6.4.8 Benelux Genome Editing and Genome Engineering Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Genome Editing and Genome Engineering Revenue, 2018-2029
6.5.2 China Genome Editing and Genome Engineering Market Size, 2018-2029
6.5.3 Japan Genome Editing and Genome Engineering Market Size, 2018-2029
6.5.4 South Korea Genome Editing and Genome Engineering Market Size, 2018-2029
6.5.5 Southeast Asia Genome Editing and Genome Engineering Market Size, 2018-2029
6.5.6 India Genome Editing and Genome Engineering Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Genome Editing and Genome Engineering Revenue, 2018-2029
6.6.2 Brazil Genome Editing and Genome Engineering Market Size, 2018-2029
6.6.3 Argentina Genome Editing and Genome Engineering Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Genome Editing and Genome Engineering Revenue, 2018-2029
6.7.2 Turkey Genome Editing and Genome Engineering Market Size, 2018-2029
6.7.3 Israel Genome Editing and Genome Engineering Market Size, 2018-2029
6.7.4 Saudi Arabia Genome Editing and Genome Engineering Market Size, 2018-2029
6.7.5 UAE Genome Editing and Genome Engineering Market Size, 2018-2029
7 Genome Editing and Genome Engineering Companies Profiles
7.1 Thermo Fisher Scientific
7.1.1 Thermo Fisher Scientific Company Summary
7.1.2 Thermo Fisher Scientific Business Overview
7.1.3 Thermo Fisher Scientific Genome Editing and Genome Engineering Major Product Offerings
7.1.4 Thermo Fisher Scientific Genome Editing and Genome Engineering Revenue in Global Market (2018-2023)
7.1.5 Thermo Fisher Scientific Key News & Latest Developments
7.2 Merck
7.2.1 Merck Company Summary
7.2.2 Merck Business Overview
7.2.3 Merck Genome Editing and Genome Engineering Major Product Offerings
7.2.4 Merck Genome Editing and Genome Engineering Revenue in Global Market (2018-2023)
7.2.5 Merck Key News & Latest Developments
7.3 Horizon Discovery
7.3.1 Horizon Discovery Company Summary
7.3.2 Horizon Discovery Business Overview
7.3.3 Horizon Discovery Genome Editing and Genome Engineering Major Product Offerings
7.3.4 Horizon Discovery Genome Editing and Genome Engineering Revenue in Global Market (2018-2023)
7.3.5 Horizon Discovery Key News & Latest Developments
7.4 Genscript
7.4.1 Genscript Company Summary
7.4.2 Genscript Business Overview
7.4.3 Genscript Genome Editing and Genome Engineering Major Product Offerings
7.4.4 Genscript Genome Editing and Genome Engineering Revenue in Global Market (2018-2023)
7.4.5 Genscript Key News & Latest Developments
7.5 Sangamo Biosciences
7.5.1 Sangamo Biosciences Company Summary
7.5.2 Sangamo Biosciences Business Overview
7.5.3 Sangamo Biosciences Genome Editing and Genome Engineering Major Product Offerings
7.5.4 Sangamo Biosciences Genome Editing and Genome Engineering Revenue in Global Market (2018-2023)
7.5.5 Sangamo Biosciences Key News & Latest Developments
7.6 Integrated DNA Technologies
7.6.1 Integrated DNA Technologies Company Summary
7.6.2 Integrated DNA Technologies Business Overview
7.6.3 Integrated DNA Technologies Genome Editing and Genome Engineering Major Product Offerings
7.6.4 Integrated DNA Technologies Genome Editing and Genome Engineering Revenue in Global Market (2018-2023)
7.6.5 Integrated DNA Technologies Key News & Latest Developments
7.7 Lonza
7.7.1 Lonza Company Summary
7.7.2 Lonza Business Overview
7.7.3 Lonza Genome Editing and Genome Engineering Major Product Offerings
7.7.4 Lonza Genome Editing and Genome Engineering Revenue in Global Market (2018-2023)
7.7.5 Lonza Key News & Latest Developments
7.8 New England Biolabs
7.8.1 New England Biolabs Company Summary
7.8.2 New England Biolabs Business Overview
7.8.3 New England Biolabs Genome Editing and Genome Engineering Major Product Offerings
7.8.4 New England Biolabs Genome Editing and Genome Engineering Revenue in Global Market (2018-2023)
7.8.5 New England Biolabs Key News & Latest Developments
7.9 Origene Technologies
7.9.1 Origene Technologies Company Summary
7.9.2 Origene Technologies Business Overview
7.9.3 Origene Technologies Genome Editing and Genome Engineering Major Product Offerings
7.9.4 Origene Technologies Genome Editing and Genome Engineering Revenue in Global Market (2018-2023)
7.9.5 Origene Technologies Key News & Latest Developments
7.10 Transposagen Biopharmaceuticals
7.10.1 Transposagen Biopharmaceuticals Company Summary
7.10.2 Transposagen Biopharmaceuticals Business Overview
7.10.3 Transposagen Biopharmaceuticals Genome Editing and Genome Engineering Major Product Offerings
7.10.4 Transposagen Biopharmaceuticals Genome Editing and Genome Engineering Revenue in Global Market (2018-2023)
7.10.5 Transposagen Biopharmaceuticals Key News & Latest Developments
7.11 Editas Medicine
7.11.1 Editas Medicine Company Summary
7.11.2 Editas Medicine Business Overview
7.11.3 Editas Medicine Genome Editing and Genome Engineering Major Product Offerings
7.11.4 Editas Medicine Genome Editing and Genome Engineering Revenue in Global Market (2018-2023)
7.11.5 Editas Medicine Key News & Latest Developments
7.12 Crispr Therapeutics
7.12.1 Crispr Therapeutics Company Summary
7.12.2 Crispr Therapeutics Business Overview
7.12.3 Crispr Therapeutics Genome Editing and Genome Engineering Major Product Offerings
7.12.4 Crispr Therapeutics Genome Editing and Genome Engineering Revenue in Global Market (2018-2023)
7.12.5 Crispr Therapeutics Key News & Latest Developments
7.13 Tecan Life Sciences
7.13.1 Tecan Life Sciences Company Summary
7.13.2 Tecan Life Sciences Business Overview
7.13.3 Tecan Life Sciences Genome Editing and Genome Engineering Major Product Offerings
7.13.4 Tecan Life Sciences Genome Editing and Genome Engineering Revenue in Global Market (2018-2023)
7.13.5 Tecan Life Sciences Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Genome Editing and Genome Engineering Market Opportunities & Trends in Global Market
Table 2. Genome Editing and Genome Engineering Market Drivers in Global Market
Table 3. Genome Editing and Genome Engineering Market Restraints in Global Market
Table 4. Key Players of Genome Editing and Genome Engineering in Global Market
Table 5. Top Genome Editing and Genome Engineering Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Genome Editing and Genome Engineering Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Genome Editing and Genome Engineering Revenue Share by Companies, 2018-2023
Table 8. Global Companies Genome Editing and Genome Engineering Product Type
Table 9. List of Global Tier 1 Genome Editing and Genome Engineering Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Genome Editing and Genome Engineering Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Genome Editing and Genome Engineering Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Genome Editing and Genome Engineering Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Genome Editing and Genome Engineering Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Genome Editing and Genome Engineering Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Genome Editing and Genome Engineering Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Genome Editing and Genome Engineering Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Genome Editing and Genome Engineering Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Genome Editing and Genome Engineering Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Genome Editing and Genome Engineering Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Genome Editing and Genome Engineering Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Genome Editing and Genome Engineering Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Genome Editing and Genome Engineering Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Genome Editing and Genome Engineering Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Genome Editing and Genome Engineering Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Genome Editing and Genome Engineering Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Genome Editing and Genome Engineering Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Genome Editing and Genome Engineering Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Genome Editing and Genome Engineering Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Genome Editing and Genome Engineering Revenue, (US$, Mn), 2024-2029
Table 30. Thermo Fisher Scientific Company Summary
Table 31. Thermo Fisher Scientific Genome Editing and Genome Engineering Product Offerings
Table 32. Thermo Fisher Scientific Genome Editing and Genome Engineering Revenue (US$, Mn) & (2018-2023)
Table 33. Thermo Fisher Scientific Key News & Latest Developments
Table 34. Merck Company Summary
Table 35. Merck Genome Editing and Genome Engineering Product Offerings
Table 36. Merck Genome Editing and Genome Engineering Revenue (US$, Mn) & (2018-2023)
Table 37. Merck Key News & Latest Developments
Table 38. Horizon Discovery Company Summary
Table 39. Horizon Discovery Genome Editing and Genome Engineering Product Offerings
Table 40. Horizon Discovery Genome Editing and Genome Engineering Revenue (US$, Mn) & (2018-2023)
Table 41. Horizon Discovery Key News & Latest Developments
Table 42. Genscript Company Summary
Table 43. Genscript Genome Editing and Genome Engineering Product Offerings
Table 44. Genscript Genome Editing and Genome Engineering Revenue (US$, Mn) & (2018-2023)
Table 45. Genscript Key News & Latest Developments
Table 46. Sangamo Biosciences Company Summary
Table 47. Sangamo Biosciences Genome Editing and Genome Engineering Product Offerings
Table 48. Sangamo Biosciences Genome Editing and Genome Engineering Revenue (US$, Mn) & (2018-2023)
Table 49. Sangamo Biosciences Key News & Latest Developments
Table 50. Integrated DNA Technologies Company Summary
Table 51. Integrated DNA Technologies Genome Editing and Genome Engineering Product Offerings
Table 52. Integrated DNA Technologies Genome Editing and Genome Engineering Revenue (US$, Mn) & (2018-2023)
Table 53. Integrated DNA Technologies Key News & Latest Developments
Table 54. Lonza Company Summary
Table 55. Lonza Genome Editing and Genome Engineering Product Offerings
Table 56. Lonza Genome Editing and Genome Engineering Revenue (US$, Mn) & (2018-2023)
Table 57. Lonza Key News & Latest Developments
Table 58. New England Biolabs Company Summary
Table 59. New England Biolabs Genome Editing and Genome Engineering Product Offerings
Table 60. New England Biolabs Genome Editing and Genome Engineering Revenue (US$, Mn) & (2018-2023)
Table 61. New England Biolabs Key News & Latest Developments
Table 62. Origene Technologies Company Summary
Table 63. Origene Technologies Genome Editing and Genome Engineering Product Offerings
Table 64. Origene Technologies Genome Editing and Genome Engineering Revenue (US$, Mn) & (2018-2023)
Table 65. Origene Technologies Key News & Latest Developments
Table 66. Transposagen Biopharmaceuticals Company Summary
Table 67. Transposagen Biopharmaceuticals Genome Editing and Genome Engineering Product Offerings
Table 68. Transposagen Biopharmaceuticals Genome Editing and Genome Engineering Revenue (US$, Mn) & (2018-2023)
Table 69. Transposagen Biopharmaceuticals Key News & Latest Developments
Table 70. Editas Medicine Company Summary
Table 71. Editas Medicine Genome Editing and Genome Engineering Product Offerings
Table 72. Editas Medicine Genome Editing and Genome Engineering Revenue (US$, Mn) & (2018-2023)
Table 73. Editas Medicine Key News & Latest Developments
Table 74. Crispr Therapeutics Company Summary
Table 75. Crispr Therapeutics Genome Editing and Genome Engineering Product Offerings
Table 76. Crispr Therapeutics Genome Editing and Genome Engineering Revenue (US$, Mn) & (2018-2023)
Table 77. Crispr Therapeutics Key News & Latest Developments
Table 78. Tecan Life Sciences Company Summary
Table 79. Tecan Life Sciences Genome Editing and Genome Engineering Product Offerings
Table 80. Tecan Life Sciences Genome Editing and Genome Engineering Revenue (US$, Mn) & (2018-2023)
Table 81. Tecan Life Sciences Key News & Latest Developments
List of Figures
Figure 1. Genome Editing and Genome Engineering Segment by Type in 2022
Figure 2. Genome Editing and Genome Engineering Segment by Application in 2022
Figure 3. Global Genome Editing and Genome Engineering Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Genome Editing and Genome Engineering Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Genome Editing and Genome Engineering Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Genome Editing and Genome Engineering Revenue in 2022
Figure 8. By Type - Global Genome Editing and Genome Engineering Revenue Market Share, 2018-2029
Figure 9. By Application - Global Genome Editing and Genome Engineering Revenue Market Share, 2018-2029
Figure 10. By Type - Global Genome Editing and Genome Engineering Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Genome Editing and Genome Engineering Revenue Market Share, 2018-2029
Figure 12. By Application - Global Genome Editing and Genome Engineering Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Genome Editing and Genome Engineering Revenue Market Share, 2018-2029
Figure 14. By Region - Global Genome Editing and Genome Engineering Revenue Market Share, 2018-2029
Figure 15. By Country - North America Genome Editing and Genome Engineering Revenue Market Share, 2018-2029
Figure 16. US Genome Editing and Genome Engineering Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Genome Editing and Genome Engineering Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Genome Editing and Genome Engineering Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Genome Editing and Genome Engineering Revenue Market Share, 2018-2029
Figure 20. Germany Genome Editing and Genome Engineering Revenue, (US$, Mn), 2018-2029
Figure 21. France Genome Editing and Genome Engineering Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Genome Editing and Genome Engineering Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Genome Editing and Genome Engineering Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Genome Editing and Genome Engineering Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Genome Editing and Genome Engineering Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Genome Editing and Genome Engineering Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Genome Editing and Genome Engineering Revenue Market Share, 2018-2029
Figure 28. China Genome Editing and Genome Engineering Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Genome Editing and Genome Engineering Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Genome Editing and Genome Engineering Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Genome Editing and Genome Engineering Revenue, (US$, Mn), 2018-2029
Figure 32. India Genome Editing and Genome Engineering Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Genome Editing and Genome Engineering Revenue Market Share, 2018-2029
Figure 34. Brazil Genome Editing and Genome Engineering Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Genome Editing and Genome Engineering Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Genome Editing and Genome Engineering Revenue Market Share, 2018-2029
Figure 37. Turkey Genome Editing and Genome Engineering Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Genome Editing and Genome Engineering Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Genome Editing and Genome Engineering Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Genome Editing and Genome Engineering Revenue, (US$, Mn), 2018-2029
Figure 41. Thermo Fisher Scientific Genome Editing and Genome Engineering Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Merck Genome Editing and Genome Engineering Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Horizon Discovery Genome Editing and Genome Engineering Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Genscript Genome Editing and Genome Engineering Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Sangamo Biosciences Genome Editing and Genome Engineering Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Integrated DNA Technologies Genome Editing and Genome Engineering Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Lonza Genome Editing and Genome Engineering Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. New England Biolabs Genome Editing and Genome Engineering Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Origene Technologies Genome Editing and Genome Engineering Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Transposagen Biopharmaceuticals Genome Editing and Genome Engineering Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Editas Medicine Genome Editing and Genome Engineering Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Crispr Therapeutics Genome Editing and Genome Engineering Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Tecan Life Sciences Genome Editing and Genome Engineering Revenue Year Over Year Growth (US$, Mn) & (2018-2023)



★調査レポート[世界のゲノム編集及びゲノム工学市場予測2023-2029:CRISPR、TALEN、ZFN] (コード:MMG23FB2185)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のゲノム編集及びゲノム工学市場予測2023-2029:CRISPR、TALEN、ZFN]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆